Sechenov School
Home › Microbiology › Human Prion Diseases

Human Prion Diseases

Transmissible spongiform encephalopathies

For medical students2 min readUpdated 2026-10-10

Human prion diseases are a group of fatal neurodegenerative disorders collectively known as transmissible spongiform encephalopathies (TSEs). They are characterized by an extremely long incubation period, severe progressive neurological dysfunction, and invariable mortality.

PathologyTransmissible spongiform encephalopathies
IncubationUp to 20–30 years from exposure
PrognosisInvariably fatal, 100% mortality
MechanismConversion of normal cellular prion protein (PrP^c) into the pathological misfolded isoform (PrP^Sc)

Classification of Spongiform Encephalopathies

This group of infectious disorders affects both humans and various animal species. The pathological process leads to hallmark changes in brain tissue, resulting in a characteristic spongy (spongiform) architecture.

Major nosological forms occurring in humans include:

Prion infections also affect animals. The most notable are scrapie in sheep and goats, and bovine spongiform encephalopathy (BSE, commonly known as "mad cow disease"). Other animal prion diseases include transmissible mink encephalopathy, feline spongiform encephalopathy, and chronic wasting disease (CWD) affecting captive and wild cervids (deer and elk).

Creutzfeldt-Jakob Disease (CJD)

CJD is the most common human prion disease, with an incubation period that can extend up to 20 years. The clinical presentation is dominated by rapidly progressive dementia, diverse movement disorders (such as myoclonus), and visual and cerebellar disturbances.

The disease occurs in two main forms:

  1. Sporadic/Classical CJD. Primarily affects older adults (mean onset around 68 years). It has an aggressive clinical course, with death typically occurring just 4–5 months after symptom onset.
  2. Variant CJD (vCJD). Affects younger individuals (mean age around 28 years). The disease course is somewhat more protracted, with death occurring within 13–14 months.

Routes of Transmission and Etiology:

Kuru

A historically significant prion disease whose epidemiology is closely tied to the island of New Guinea, where it affected indigenous Fore people. The infectious nature of Kuru was famously demonstrated by D. Carleton Gajdusek.

The primary transmission route was alimentary, occurring through ritual endocannibalism in which grieving relatives consumed the brains of deceased family members without adequate thermal processing.

The clinical presentation of Kuru includes:

The prognosis for Kuru is uniformly fatal, with death occurring within 1 year of symptom onset.

Inherited Prion Syndromes

In addition to acquired forms, there are hereditary prion diseases with a strong familial aggregation.

Gerstmann-Sträussler-Scheinker (GSS) syndrome is an inherited autosomal dominant disorder with an incubation period ranging from 5 to 30 years. Clinical features include ataxia, cognitive decline progressing to dementia, hyporeflexia, and bulbar symptoms (dysphagia, dysarthria). The disease inexorably progresses, resulting in death 4–5 years after onset.

Fatal familial insomnia (FFI) is an autosomal dominant inherited prion disease. The hallmark manifestation is progressive intractable insomnia leading to a total disruption of circadian rhythms. This state is accompanied by sympathetic hyperactivity: patients exhibit tachycardia, hypertension, hyperthermia, and excessive sweating (hyperhidrosis). Later in the disease course, severe neurological deficits emerge, including myoclonus, ataxia, tremors, and hallucinations. The direct cause of death is typically progressive cardiovascular collapse.

Mnemonic

To remember the primary mechanisms of Creutzfeldt-Jakob disease, use the mnemonic "I-S-A": Iatrogenic (medical), Sporadic/Genetic (mutations), and Alimentary (contaminated food).

Frequently asked questions

What are the structural differences between the pathological prion protein (PrP^Sc) and the normal cellular protein (PrP^c)?

The structural difference between the pathological prion PrP^Sc and the normal host protein PrP^c involves a conformational shift and altered physicochemical properties.

FeatureNormal Protein (PrP^c)Pathological Prion (PrP^Sc)
$\beta$-sheet content~3%>40%
Molecular weight—Decreased fragment: 27–30 kDa
PropertiesSoluble, protease-sensitiveHydrophobic, prone to amyloid fibril and plaque formation

The pathological isoform arises from post-translational conformational conversion and accumulates within intracellular vesicles.

What laboratory diagnostic methods are used for the antemortem confirmation of prion diseases?

Definitive antemortem confirmation of prion diseases requires CNS tissue biopsy.

Additional diagnostic modalities include:

  • Neuropathology — identification of spongiform changes, astrogliosis, and amyloid staining in brain tissue, notably in the absence of inflammatory infiltrates.
  • Immunochemical methods — detection of surrogate protein markers of neuronal injury in cerebrospinal fluid (CSF) using ELISA and real-time quaking-induced conversion (RT-QuIC) assays.
  • Molecular genetic testing — sequencing of the PRNP gene to detect pathogenic mutations or insertions.
How resilient are prions to standard sterilization and disinfection methods?

Prions exhibit extreme resistance to conventional sterilization and disinfection protocols. Standard decontamination procedures, including routine formalin fixation and standard autoclaving, do not reliably eliminate infectivity.

Inactivation requires harsh conditions:

  • Autoclaving — at 134 °C for 30–60 minutes, or 121 °C for 4 hours, often combined with sodium hydroxide (NaOH).
  • Chemical treatment — immersion in sodium hypochlorite (bleach) or 1N NaOH for 1 hour.
  • Incineration — definitive disposal method for contaminated instruments and materials.

Furthermore, pathological prions are highly resistant to proteolysis, high temperatures, ionizing radiation, and $\beta$-propiolactone.

What histopathological brain changes characterize transmissible spongiform encephalopathies?

Transmissible spongiform encephalopathies are characterized by spongiform degeneration, neuronal loss, astrogliosis, amyloid plaque deposition, and the absence of inflammatory infiltrates.

  • Spongiosis — appearance of multiple round or oval vacuoles within the neuropil and neuronal perikarya; coalescence of vacuoles forms microcysts that disrupt cortical cytoarchitecture.
  • Neuronal changes — progressive vacuolar degeneration and neuronal loss; surviving neurons often appear shrunken and hyperchromic.
  • Glial response — robust proliferation of glial elements and marked astrogliosis.
  • Amyloid plaques — deposition of PrP^Sc-containing amyloid plaques (frequently observed in the cerebellum in GSS syndrome).
  • Absence of inflammation — a critical diagnostic feature is the lack of perivascular inflammatory infiltrates or lymphocytic exudation.

Macroscopic examination typically reveals cerebral cortical atrophy and ventricular enlargement.

What is the main difference between classical and variant CJD?

Classical CJD typically affects older adults (mean age 68) with rapid death in 4–5 months. Variant CJD affects younger individuals (mean age ~28) and has a slightly longer duration of 13–14 months.

How can a patient contract a prion infection in a healthcare setting?

Iatrogenic transmission occurs via inadequately sterilized neurosurgical instruments, contaminated surgical materials (like dura mater grafts), blood transfusions, corneal or tissue transplants, and administration of animal-derived or human cadaveric hormones.

What is the direct cause of death in fatal familial insomnia?

Despite profound neurological deterioration, the direct cause of death in these patients is progressive cardiovascular failure.

Go deeper

More topics in Microbiology

Skin Immune SystemSystemic Lupus ErythematosusViral PathogenicitySerological Diagnostic MethodsImmunity in Viral Respiratory InfectionsSporotrichosisChlamydiaBacterial RespirationBacterial Gene Transfer MechanismsClusters of Differentiation (CD Markers): Anatomy and FunctionProbiotics: Mechanisms, Indications and Clinical ApplicationComplement-Mediated Serological ReactionsMicrobiology →